Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 100

Results For "diseases"

1272 News Found

Nipah survivors study to advance new vaccines against highly fatal threat
Biotech | March 16, 2022

Nipah survivors study to advance new vaccines against highly fatal threat

CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus


Experts call for capacity building to combat Antimicrobial Resistance
Sustainability | March 16, 2022

Experts call for capacity building to combat Antimicrobial Resistance

The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific


Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA
Biotech | March 16, 2022

Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA

The USFDA has granted a qualified infectious disease product (QIDP) designation to WCK 6777, which signifies its ability to meet unmet medical needs and facilitates a faster approval process


UFDA approves first generic of Symbicort to treat asthma and COPD
Drug Approval | March 16, 2022

UFDA approves first generic of Symbicort to treat asthma and COPD

This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)


Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation
Biotech | March 15, 2022

Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation

Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder


Draft policy on medical devices released
Policy | March 14, 2022

Draft policy on medical devices released

Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022


Clarivate deals report highlights emerging trends in biopharma deal-making
Biotech | March 14, 2022

Clarivate deals report highlights emerging trends in biopharma deal-making

RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape


Illumina and Trivitron collaborate for next-generation sequencing in India
Medical Device | March 14, 2022

Illumina and Trivitron collaborate for next-generation sequencing in India

In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches


Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine
News | March 14, 2022

Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine

The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines


Wipro and Pandorum partner to accelerate regenerative medicine with AI
News | March 12, 2022

Wipro and Pandorum partner to accelerate regenerative medicine with AI

Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes